NASDAQ:NUVA
Delisted
NuVasive Stock News
$39.75
+0 (+0%)
At Close: Nov 30, 2023
Radcliffe Capital Management, L.P. Acquires Stake in Portage Fintech Acquisition Corp
04:37pm, Thursday, 27'th Jul 2023
Radcliffe Capital Management, L.P. (Trades, Portfolio), a prominent investment firm, recently made a significant acquisition in the stock market.
NuVasive (NUVA) Q1 Earnings Beat Estimates, Margins Fall
12:57pm, Thursday, 11'th May 2023
NuVasive's (NUVA) strong sales across the U.S. Spinal Hardware and U.S. Surgical Support businesses instill optimism.
NuVasive, Inc. (NUVA) Q1 2023 Earnings Call Transcript
10:15pm, Wednesday, 10'th May 2023
NuVasive, Inc. (NASDAQ:NUVA ) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Juliet Cunningham - Vice President, Investor Relations Chris Barry - Chief Executive Officer
NuVasive (NUVA) Tops Q1 Earnings and Revenue Estimates
06:59pm, Wednesday, 10'th May 2023
NuVasive (NUVA) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.54 per share a year ago.
Globus Medical: Still Very Attractive After NuVasive Selloff
05:41am, Thursday, 04'th May 2023
Globus Medical caught headlines after announcing the NuVasive merger. Investors have wiped out considerable equity post-announcement, but the worst may be now priced in.
Is NuVasive (NUVA) a Great Value Stock Right Now?
11:25am, Monday, 01'st May 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
New Strong Buy Stocks for April 26th
09:08am, Wednesday, 26'th Apr 2023
EGY, MSGS, NUVA, NWG and VCISY have been added to the Zacks Rank #1 (Strong Buy) List on April 26, 2022.
NUVA vs. ABT: Which Stock Is the Better Value Option?
12:57pm, Tuesday, 25'th Apr 2023
Investors looking for stocks in the Medical - Products sector might want to consider either NuVasive (NUVA) or Abbott (ABT). But which of these two stocks is more attractive to value investors?
Why Is NuVasive (NUVA) Down 15.9% Since Last Earnings Report?
12:59pm, Friday, 24'th Mar 2023
NuVasive (NUVA) reported earnings 30 days ago. What's next for the stock?
NuVasive's (NUVA) Precice System Cleared for Pediatric Patients
09:13am, Tuesday, 21'st Mar 2023
NuVasive (NUVA) receives FDA 510(k) clearance for using the Precice limb lengthening system for treating pediatric patients.
NuVasive (NUVA), GMED Merger Aids, Macro Woes Mar Growth
11:30am, Friday, 17'th Mar 2023
According to NuVasive (NUVA), the combined company is set to have an advanced commercial scale and portfolio of clinically proven solutions.
Bear of the Day: NuVasive (NUVA)
07:32am, Thursday, 02'nd Mar 2023
Softer results for spinal surgery innovator plus questionable merger have dropped estimates and shares
NuVasive to Participate in Upcoming Investor Conferences
04:10pm, Monday, 27'th Feb 2023
SAN DIEGO , Feb. 27, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integr
NuVasive (NUVA) Q4 Earnings Miss Estimates, Margins Down
12:48pm, Thursday, 23'rd Feb 2023
Inflationary costs, supply chain disruptions, volatility in foreign exchange rates and the persistent COVID-led impact hurt NuVasive's (NUVA) Q4 revenues.
NuVasive, Inc. (NUVA) Q4 2022 Earnings Call Transcript
09:08pm, Wednesday, 22'nd Feb 2023
NuVasive, Inc. (NASDAQ:NUVA ) Q4 2022 Earnings Conference Call February 22, 2023 4:30 PM ET Company Participants Juliet Cunningham - VP, IR Christopher Barry - CEO & Director Matthew Harbaugh - EVP &
